Safety Alert: Ibandronate Sodium

Update on FDA Safety Review of Bisphosphonates

The FDA has issued a finalized safety review on bisphosphonates, like Ibandronate (Boniva), and found no link between these medications and atrial fibrillation - an abnormal heart rhythm commonly known as "afib".

Bisphosphonates are a type of medicine commonly used to treat patients with osteoporosis.

For more information please visit:

more information here

Source: FDA
Publication Date: 2008-Nov-14
Last Updated: 2009-Jun-05

What does this mean?

Despite previous concerns regarding the use of bisphosphonates and abnormal heart rhythms, the results of the FDA's safety review should be reassuring if you are still using Ibandronate (Boniva).

Vist theIbandronate Sodium medication page for more information about Ibandronate Sodium.

DISCLAIMER: iGuard is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Bookmark and Share